Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: A real-time pcr assay for direct detection of the neisseria gonorrhoeae h041 strain

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 902-905

  Goire, Namraj ^a,b   Ohnishi, Makoto ^c   Limnios, Athena E ^d   Lahra, Monica M ^d   Lambert, Stephen B ^a,b   Nimmo, Graeme R ^e,f   Nissen, Michael D ^a,b,e   Sloots, Theo P ^a,b,e   Whiley, David M ^a,b  

^a Queensland Children's Medical Research Institute   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e Central Queensland Pathology Laboratory   (Australia)

^f GRIFFITH UNIVERSITY   (Australia)

Author keywords

Diagnostics; Epidemiology; Gonorrhoea; PenA

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CEFTRIAXONE; PENA PROTEIN; PENICILLIN BINDING PROTEIN 2A; PORIN A; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; CROSS REACTION; DNA SEQUENCE; LIMIT OF DETECTION; NEISSERIA; NEISSERIA GONORRHOEAE; NEISSERIA SUBFLAVA; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CEFTRIAXONE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GONORRHEA; HUMANS; JAPAN; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84858626063     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr549     Document Type: Article

References (10)

1. Ohnishi M, Saika T, Hoshina S et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 2011; 17: 148-9.
2. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
3. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 2009; 22: 87-91.
4. Tapsall JW, Ndowa F, Lewis DA et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009; 7: 821-34.
5. Whiley DM, Faux CE, Bialasiewicz S et al. A simple approach for preparing real-time PCR positive reaction controls for rare or emerging viruses. J Clin Virol 2010; 48: 193-7.
6. Whiley DM, Limnios EA, Ray S et al. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111-6.
7. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
8. Goire N, Nissen MD, LeCornec GM et al. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 2008; 61: 6-12.
9. Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 2005; 49: 137-43.
10. Whiley DM, Tapsall JW, Sloots TP et al. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn 2006; 8: 3-15.